WO2002096444A3 - Composition a effet therapeutique - Google Patents

Composition a effet therapeutique Download PDF

Info

Publication number
WO2002096444A3
WO2002096444A3 PCT/DE2002/001958 DE0201958W WO02096444A3 WO 2002096444 A3 WO2002096444 A3 WO 2002096444A3 DE 0201958 W DE0201958 W DE 0201958W WO 02096444 A3 WO02096444 A3 WO 02096444A3
Authority
WO
WIPO (PCT)
Prior art keywords
constituents
plumbago
europaea
composition
natural origin
Prior art date
Application number
PCT/DE2002/001958
Other languages
German (de)
English (en)
Other versions
WO2002096444A2 (fr
Inventor
Sofia Karassalidou-Mueller
Original Assignee
Sofia Karassalidou-Mueller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sofia Karassalidou-Mueller filed Critical Sofia Karassalidou-Mueller
Priority to AU2002317678A priority Critical patent/AU2002317678A1/en
Publication of WO2002096444A2 publication Critical patent/WO2002096444A2/fr
Publication of WO2002096444A3 publication Critical patent/WO2002096444A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

L'invention concerne une composition à effet thérapeutique, des utilisations de la composition selon l'invention ainsi qu'un procédé de fabrication de celle-ci. L'invention vise à mettre en oeuvre un agent destiné au traitement thérapeutique du psoriasis, se révélant efficace et ne présentant ni effet cytotoxique ni effets secondaires. A cet effet, la composition selon l'invention contient des constituants de la plante Plumbago europaea et au moins un autre constituant d'origine naturelle. Les constituants de la plante Plumbago europaea associés à d'autres constituants d'origine naturelle tels que par exemple des produits laitiers ou des extraits d'ail, présentent en application externe un effet thérapeutique notoire, sans effets secondaires indésirables, à l'exception de démangeaisons cutanées passagères au début du traitement. Comme la composition selon l'invention est d'origine naturelle, aucun effet cytotoxique n'est observé.
PCT/DE2002/001958 2001-05-28 2002-05-28 Composition a effet therapeutique WO2002096444A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002317678A AU2002317678A1 (en) 2001-05-28 2002-05-28 Plumbago europaea constituents for use against psoriasis and hair loss

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10126023.7 2001-05-28
DE10126023A DE10126023A1 (de) 2001-05-28 2001-05-28 Zusammensetzung mit therapeutischer Wirksamkeit

Publications (2)

Publication Number Publication Date
WO2002096444A2 WO2002096444A2 (fr) 2002-12-05
WO2002096444A3 true WO2002096444A3 (fr) 2003-12-04

Family

ID=7686453

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2002/001958 WO2002096444A2 (fr) 2001-05-28 2002-05-28 Composition a effet therapeutique

Country Status (3)

Country Link
AU (1) AU2002317678A1 (fr)
DE (1) DE10126023A1 (fr)
WO (1) WO2002096444A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007040025A1 (de) * 2007-08-24 2009-02-26 Muhamad Karwan Haarwuchsmittel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080401A (en) * 1998-11-19 2000-06-27 Reddy; Malireddy S. Herbal and pharmaceutical drugs enhanced with probiotics

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
DATABASE MEDLINE [online] April 1997 (1997-04-01), KINI D P ET AL: "Antitumor and antifertility activities of plumbagin controlled release formulations.", XP002217228, Database accession no. NLM9315238 *
DATABASE MEDLINE [online] June 1977 (1977-06-01), PREMAKUMARI P ET AL: "Antifertility activity of plumbagin.", XP002217227, Database accession no. NLM12260179 *
GRIEVE M,LEYEL CF: "A MODERN HERBAL", 1981, MOUNTAIN ROSE HERBS, XP002217226 *
INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY. INDIA APR 1997, vol. 35, no. 4, April 1997 (1997-04-01), pages 374 - 379, ISSN: 0019-5189 *
NAHALKA J ET AL: "Production of plumbagin by cell suspension cultures of Drosophyllum lusitanicum Link", JOURNAL OF BIOTECHNOLOGY, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 49, no. 1, 20 August 1996 (1996-08-20), pages 153 - 161, XP004037103, ISSN: 0168-1656 *
THE INDIAN JOURNAL OF MEDICAL RESEARCH. UNITED STATES JUN 1977, vol. 65, no. 6, June 1977 (1977-06-01), pages 829 - 838, ISSN: 0971-5916 *

Also Published As

Publication number Publication date
WO2002096444A2 (fr) 2002-12-05
DE10126023A1 (de) 2002-12-12
AU2002317678A1 (en) 2002-12-09

Similar Documents

Publication Publication Date Title
WO2001015678A3 (fr) Utilisation topique d'agonistes des kappa opioides afin de traiter les douleurs oculaires
WO1998010767A3 (fr) Utilisation de derives de la quinazoline pour la fabrication d'un medicament destine au traitement de troubles cutanes hyperproliferatifs
BRPI0006634B8 (pt) composição tópica compreendendo extrato de matricária no tratamento e prevenção de distúrbios inflamatórios
PL370795A1 (en) Composition based on etyllinoleate and triethylcitrate for the treatment of seborrhea and acne
EP1303284A4 (fr) Compositions et procedes pour traiter des dommages cutanes
WO2003068171A3 (fr) Procede et composition pour le traitement d'une inflammation et de troubles neurologiques associes au sida
WO2001074314A3 (fr) Compositions cosmetiques et pharmaceutiques et procedes d'utilisation de derives 2-decarboxy-2-phosphinico
BR0007404A (pt) Composições de soja para despigmentação e cuidado com a pele
TW200505490A (en) Cosmetic compositions and methods for using same to improve the aesthetic appearance of skin
CA2173457A1 (fr) Utilisation des inhibiteurs de la 5-alpha reductase et compositions pour le traitement de l'alopecie androgenique
WO2006068778A3 (fr) Utilisation d'extraits vegetaux pour la prevention et/ou la reduction de signes de malaise subjectif et/ou d'irritation dans l'application topique de produits cosmetiques
BR0212576A (pt) Método para o tratamento de distúrbios da pele
WO2003092617A3 (fr) Combinaisons destinees au traitement de troubles cutanes inflammatoires
WO2002007669A3 (fr) Derives phospholipides de l'acide valproique et leurs melanges
WO2004060289A3 (fr) Utilisation de pourpier pour le traitement de rides du visage
TW200513271A (en) Topical treatment of skin conditions
WO2004017924A3 (fr) Methodes de traitement des spasmes faciaux et des rides du visage
CA2275167A1 (fr) Utilisation locale d'agonistes opioides kappa dans le traitement de la douleur oculaire
WO2003039453A3 (fr) Compositions de peroxyde de dibenzoyle pour le traitement de troubles dermatologiques, et procedes d'utilisation correspondants
WO2003013554A3 (fr) Inhibiteurs de l'aromatase provenant de broussonetia papyrifera
WO2004103353A3 (fr) Traitement topique de problemes de peau
MXPA04001289A (es) Composicion cosmetica y metodo para tratar la piel.
WO2001015677A3 (fr) Utilisation d'agonistes de 5-ht1b/1d pour le traitement des douleurs oculaires
WO2003049667A3 (fr) Methode de traitement du cancer
WO2004105689A3 (fr) Composition s'appliquant localement afin de traiter des lesions epidermiques et ses methodes d'utilisation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP